Ptosis
发表于 2025-3-28 15:53:28
MRA Inhibition in CKD: More Than Salt and Water status and blood pressure. In this chapter we will describe the non-conventional renal and extrarenal effects of aldosterone, and review the effects of mineralocorticoid receptor antagonists in cardiovascular diseases and chronic kidney disease.
moribund
发表于 2025-3-28 20:57:49
http://reply.papertrans.cn/23/2219/221855/221855_42.png
蒙太奇
发表于 2025-3-28 23:39:22
http://reply.papertrans.cn/23/2219/221855/221855_43.png
用手捏
发表于 2025-3-29 03:22:13
http://reply.papertrans.cn/23/2219/221855/221855_44.png
myelography
发表于 2025-3-29 08:44:36
How to Use Inhibitors of the Renin-Angiotensin-Aldosterone System in Patients with CKD and Heart FaiRD) patients had HF at initiation of dialysis and more than half of these manifested recurrence of HF later on, whereas among patients without previous HF, 25 % subsequently developed HF during dialysis. However, the Dialysis Outcomes and Practice Patterns Study (DOPPS) showed considerable geographi
inscribe
发表于 2025-3-29 14:03:43
Atemwegssicherung, Intubation und Beatmung, status and blood pressure. In this chapter we will describe the non-conventional renal and extrarenal effects of aldosterone, and review the effects of mineralocorticoid receptor antagonists in cardiovascular diseases and chronic kidney disease.
LOPE
发表于 2025-3-29 17:33:06
http://reply.papertrans.cn/23/2219/221855/221855_47.png
Pamphlet
发表于 2025-3-29 23:32:17
http://reply.papertrans.cn/23/2219/221855/221855_48.png
消极词汇
发表于 2025-3-30 03:14:23
http://reply.papertrans.cn/23/2219/221855/221855_49.png
finale
发表于 2025-3-30 06:48:05
,Grundlegende notfallmedizinische Maßnahmen,RD) patients had HF at initiation of dialysis and more than half of these manifested recurrence of HF later on, whereas among patients without previous HF, 25 % subsequently developed HF during dialysis. However, the Dialysis Outcomes and Practice Patterns Study (DOPPS) showed considerable geographi